| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18832879 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 105 journal articles in the PubMed database | Email to a friend | | |
| Gallant JE, Winston JA, DeJesus E, et al.
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients. [Journal Article]
AIDS 2008 Oct 18; 22(16):2155-63.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Izzedine H, Hulot JS, Vittecoq D, et al.
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Nephrol Dial Transplant 2005 Apr; 20(4):743-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Gallant JE, Staszewski S, Pozniak AL, et al.
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2004 Jul 14; 292(2):191-201.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Arribas JR, Pozniak AL, Gallant JE, et al.
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients: 144-Week Analysis. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2007 Oct 25.
Abstract | Full Citation | Find Related Articles | | Pozniak AL, Gallant JE, Dejesus E, et al.
Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Versus Fixed-Dose Zidovudine/Lamivudine and Efavirenz in Antiretroviral-Naive Patients: Virologic, Immunologic, and Morphologic Changes: A 96-Week Analysis. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2006 Oct 12.
Abstract | Full Citation | Find Related Articles | | Goicoechea M, Liu S, Best B, et al.
Greater Tenofovir-Associated Renal Function Decline with Protease Inhibitor-Based versus Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy. [JOURNAL ARTICLE]
J Infect Dis 2008 Jan 1; 197(1):102-108.
Abstract | Full Citation | Find Related Articles | | Buchacz K, Brooks JT, Tong T, et al.
Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy. [Journal Article]
HIV Med 2006 Oct; 7(7):451-6.
Abstract | Full Citation | Find Related Articles | | Gérard L, Chazallon C, Taburet AM, et al.
Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir. [Journal Article, Research Support, Non-U.S. Gov't]
Antivir Ther 2007; 12(1):31-9.
Abstract | Full Citation | Find Related Articles | | Emtricitabine/tenofovir disoproxil fumarate. [Journal Article, Review]
Drugs R D 2004; 5(3):160-1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
